v3.26.1
Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited) - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Oct. 31, 2024   938,989      
Balance at the beginning of period at Oct. 31, 2024 $ (1,323) $ 9 $ 1,778 $ (2,676) $ (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 565     565  
Other comprehensive income (loss), net of taxes 230       230
Comprehensive income (loss) 795        
Issuance of common stock in connection with employee stock plans and other (in shares)   8,405      
Issuance of common stock in connection with employee stock plans and other (92)   (92)    
Repurchases of common stock (in shares)   (2,734)      
Repurchases of common stock (Note 9) (97)   (4) (93)  
Cash dividends (547)     (547)  
Stock-based compensation expense 192   192    
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the end of period at Jan. 31, 2025 (1,072) $ 9 1,874 (2,751) (204)
Balance (in shares) at Oct. 31, 2024   938,989      
Balance at the beginning of period at Oct. 31, 2024 (1,323) $ 9 1,778 (2,676) (434)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,734        
Other comprehensive income (loss), net of taxes (207)        
Comprehensive income (loss) $ 1,527        
Repurchases of common stock (in shares) (11,400)        
Balance (in shares) at Jul. 31, 2025   938,765      
Balance at the end of period at Jul. 31, 2025 $ (901) $ 9 2,091 (2,360) (641)
Balance (in shares) at Jan. 31, 2025   944,660      
Balance at the beginning of period at Jan. 31, 2025 (1,072) $ 9 1,874 (2,751) (204)
Increase (Decrease) in Stockholders' Equity          
Net earnings 406     406  
Other comprehensive income (loss), net of taxes (639)       (639)
Comprehensive income (loss) (233)        
Issuance of common stock in connection with employee stock plans and other (in shares)   667      
Issuance of common stock in connection with employee stock plans and other (9)   (9)    
Repurchases of common stock (in shares)   (3,118)      
Repurchases of common stock (Note 9) (103)   (6) (97)  
Cash dividends 1     1  
Stock-based compensation expense 140   140    
Balance (in shares) at Apr. 30, 2025   942,209      
Balance at the end of period at Apr. 30, 2025 (1,276) $ 9 1,999 (2,441) (843)
Increase (Decrease) in Stockholders' Equity          
Net earnings 763     763  
Other comprehensive income (loss), net of taxes 202       202
Comprehensive income (loss) 965        
Issuance of common stock in connection with employee stock plans and other (in shares)   2,057      
Issuance of common stock in connection with employee stock plans and other $ 5   5    
Repurchases of common stock (in shares) (5,500) (5,501)      
Repurchases of common stock (Note 9) $ (152)   (13) (139)  
Cash dividends (543)     (543)  
Stock-based compensation expense 100   100    
Balance (in shares) at Jul. 31, 2025   938,765      
Balance at the end of period at Jul. 31, 2025 $ (901) $ 9 2,091 (2,360) (641)
Balance (in shares) at Oct. 31, 2025 921,000 921,149      
Balance at the beginning of period at Oct. 31, 2025 $ (346) $ 9 2,129 (2,027) (457)
Increase (Decrease) in Stockholders' Equity          
Net earnings 545     545  
Other comprehensive income (loss), net of taxes (197)       (197)
Comprehensive income (loss) 348        
Issuance of common stock in connection with employee stock plans and other (in shares)   9,385      
Issuance of common stock in connection with employee stock plans and other (73)   (73)    
Repurchases of common stock (in shares)   (13,360)      
Repurchases of common stock (Note 9) (325)   (31) (294)  
Cash dividends (552)     (552)  
Stock-based compensation expense 182   182    
Balance (in shares) at Jan. 31, 2026   917,174      
Balance at the end of period at Jan. 31, 2026 $ (766) $ 9 2,207 (2,328) (654)
Balance (in shares) at Oct. 31, 2025 921,000 921,149      
Balance at the beginning of period at Oct. 31, 2025 $ (346) $ 9 2,129 (2,027) (457)
Increase (Decrease) in Stockholders' Equity          
Net earnings 1,656        
Other comprehensive income (loss), net of taxes 109        
Comprehensive income (loss) $ 1,765        
Repurchases of common stock (in shares) (30,500)        
Balance (in shares) at Jul. 31, 2026 903,000 903,409      
Balance at the end of period at Jul. 31, 2026 $ (92) $ 9 2,364 (2,117) (348)
Balance (in shares) at Jan. 31, 2026   917,174      
Balance at the beginning of period at Jan. 31, 2026 (766) $ 9 2,207 (2,328) (654)
Increase (Decrease) in Stockholders' Equity          
Net earnings 450     450  
Other comprehensive income (loss), net of taxes 153       153
Comprehensive income (loss) 603        
Issuance of common stock in connection with employee stock plans and other (in shares)   2,213      
Issuance of common stock in connection with employee stock plans and other (2)   (2)    
Repurchases of common stock (in shares)   (4,977)      
Repurchases of common stock (Note 9) (95)   (12) (83)  
Cash dividends 1     1  
Stock-based compensation expense 115   115    
Balance (in shares) at Apr. 30, 2026   914,410      
Balance at the end of period at Apr. 30, 2026 (144) $ 9 2,308 (1,960) (501)
Increase (Decrease) in Stockholders' Equity          
Net earnings 661     661  
Other comprehensive income (loss), net of taxes 153       153
Comprehensive income (loss) 814        
Issuance of common stock in connection with employee stock plans and other (in shares)   1,195      
Issuance of common stock in connection with employee stock plans and other $ (11)   (11)    
Repurchases of common stock (in shares) (12,200) (12,196)      
Repurchases of common stock (Note 9) $ (303)   (32) (271)  
Cash dividends (547)     (547)  
Stock-based compensation expense $ 99   99    
Balance (in shares) at Jul. 31, 2026 903,000 903,409      
Balance at the end of period at Jul. 31, 2026 $ (92) $ 9 $ 2,364 $ (2,117) $ (348)